The blog · Topic

Mouse, Dish or Human?

5 posts on Mouse, Dish or Human?, newest first. All posts →

2026

  1. Mouse Dish or Human?

    An 80-year-old's blood cells were made 60 years 'younger' in a dish. A dish result is a dish result.

    Researchers at the University of Bonn announced today, in Aging Cell, that they had converted blood-cell precursors from an 80-year-old donor directly into neural stem cells and watched the cells' epigenetic age — the DNA-methylation clock reading — fall to under 20 years over…

    4 min read
  2. Mouse Dish or Human?

    Mouse, dish or human? Semaglutide extended lifespan in old female mice by 92 days.

    A paper in Nature today, with a same-day release from the National Institutes of Health, reports that semaglutide — the molecule in Wegovy — given to female mice from 20 months of age extended their median lifespan from 742 days to 834, about 12%.

    4 min read
  3. Evidence · Mouse Dish or Human?

    A model says the ceiling on human life is 146 to 194 years. A model is a model.

    A paper published last month in npj Aging is making the rounds this week under headlines about living to 190. The authors built a mathematical model in which the body is a chain of critical organs, each losing cells to lethal mutations over time, and asked how long a person would…

    4 min read
  4. Evidence · Mouse Dish or Human?

    The first reprogramming therapy is cleared for a human trial. 'Cleared to test' and 'shown to work' are different sentences.

    Life Biosciences announced today that the FDA has cleared its investigational new drug application for ER-100, which the company describes as the first cellular rejuvenation therapy using epigenetic reprogramming to be allowed into human trials.

    4 min read

2025

  1. Follow the Money · Mouse Dish or Human?

    One of the world's largest drugmakers just bought into cellular reprogramming. Read what 'clinical' means here.

    NewLimit, the San Francisco company working on epigenetic reprogramming — resetting the chemical marks that tell a cell how old to act — announced today an additional $45 million from Eli Lilly, Duke University's endowment, Section 32 and existing investors, at a $1.62 billion…

    4 min read